Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruijiang Zeng

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pathology, Research and Practice|September 12, 2022
Effect of NMB-regulated ERK1/2 and p65 signaling pathway on proliferation and apoptosis of cervical cancerRuijiang Zeng, Xiangyang Xiong
Cancers|June 24, 2022
The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer CachexiaRuijiang Zeng, Chang Tong, Xiangyang Xiong
Nature Communications|January 15, 2026
Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactateMing Xiao, Wanyang Guo, Ruijiang Zeng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2026
ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1/Hippo signaling pathwayMengmeng Wang, Li Gu, Ruijiang Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 10, 2023
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate CancerHuaiyuan Liang, Chunguang Yang, Ruijiang Zeng, et al.
Cell Death and Differentiation|March 22, 2024
Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancerDa Ren, Wei Li, Ruijiang Zeng, et al.
Cell Reports|November 6, 2025
Diet-metabolism-transcription axis modulates the sensitivity to CDK4/6 inhibitors through RB1 in prostate cancerXurui Li, Zhenghui Sun, Ruijiang Zeng, et al.
Cancer Research|June 11, 2024
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate CancerWei Li, Feng Guo, Ruijiang Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2025
ZDHHC2-Dependent Palmitoylation Dictates Ferroptosis and Castration Sensitivity in Prostate Cancer via Controlling ACSL4 Degradation and Lipid PeroxidationShuai Shao, Wei Li, Yulong Hong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 11, 2026
Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma ProgressionRuijiang Zeng, Mengmeng Wang, Kang Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pathology, Research and Practice|September 12, 2022
Effect of NMB-regulated ERK1/2 and p65 signaling pathway on proliferation and apoptosis of cervical cancerRuijiang Zeng, Xiangyang Xiong
Cancers|June 24, 2022
The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer CachexiaRuijiang Zeng, Chang Tong, Xiangyang Xiong
Nature Communications|January 15, 2026
Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactateMing Xiao, Wanyang Guo, Ruijiang Zeng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2026
ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1/Hippo signaling pathwayMengmeng Wang, Li Gu, Ruijiang Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 10, 2023
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate CancerHuaiyuan Liang, Chunguang Yang, Ruijiang Zeng, et al.
Cell Death and Differentiation|March 22, 2024
Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancerDa Ren, Wei Li, Ruijiang Zeng, et al.
Cell Reports|November 6, 2025
Diet-metabolism-transcription axis modulates the sensitivity to CDK4/6 inhibitors through RB1 in prostate cancerXurui Li, Zhenghui Sun, Ruijiang Zeng, et al.
Cancer Research|June 11, 2024
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate CancerWei Li, Feng Guo, Ruijiang Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2025
ZDHHC2-Dependent Palmitoylation Dictates Ferroptosis and Castration Sensitivity in Prostate Cancer via Controlling ACSL4 Degradation and Lipid PeroxidationShuai Shao, Wei Li, Yulong Hong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 11, 2026
Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma ProgressionRuijiang Zeng, Mengmeng Wang, Kang Wang, et al.
Pageof 2